Design of potent and selective 2-aminobenzimidazole-based p38alpha MAP kinase inhibitors with excellent in vivo efficacy.

Source:http://linkedlifedata.com/resource/pubmed/id/15801819

J. Med. Chem. 2005 Apr 7 48 7 2270-3

Download in:

View as

General Info

PMID
15801819